These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
549 related items for PubMed ID: 25195579
1. Epigenomic networking in drug development: from pathogenic mechanisms to pharmacogenomics. Cacabelos R. Drug Dev Res; 2014 Sep; 75(6):348-65. PubMed ID: 25195579 [Abstract] [Full Text] [Related]
6. Histone deacetylation in epigenetics: an attractive target for anticancer therapy. Mai A, Massa S, Rotili D, Cerbara I, Valente S, Pezzi R, Simeoni S, Ragno R. Med Res Rev; 2005 May; 25(3):261-309. PubMed ID: 15717297 [Abstract] [Full Text] [Related]
7. Novel cancer drugs based on epigenetics, miRNAs and their interactions. Roukos DH. Epigenomics; 2011 Dec; 3(6):675-8. PubMed ID: 22126285 [No Abstract] [Full Text] [Related]
8. Epigenetic therapy in cancer: molecular background and clinical development of histone deacetylase and DNA methyltransferase inhibitors. Schneider-Stock R, Ocker M. IDrugs; 2007 Aug; 10(8):557-61. PubMed ID: 17665331 [Abstract] [Full Text] [Related]
11. Epigenetics in prostate cancer: biologic and clinical relevance. Jerónimo C, Bastian PJ, Bjartell A, Carbone GM, Catto JW, Clark SJ, Henrique R, Nelson WG, Shariat SF. Eur Urol; 2011 Oct; 60(4):753-66. PubMed ID: 21719191 [Abstract] [Full Text] [Related]
12. Epigenetic small molecule modulators of histone and DNA methylation. Hauser AT, Robaa D, Jung M. Curr Opin Chem Biol; 2018 Aug; 45():73-85. PubMed ID: 29579619 [Abstract] [Full Text] [Related]
13. Epigenetic Regulatory Mechanisms Induced by Resveratrol. Fernandes GFS, Silva GDB, Pavan AR, Chiba DE, Chin CM, Dos Santos JL. Nutrients; 2017 Nov 01; 9(11):. PubMed ID: 29104258 [Abstract] [Full Text] [Related]
14. Epigenetic regulation in myelodysplastic syndromes: implications for therapy. Vigna E, Recchia AG, Madeo A, Gentile M, Bossio S, Mazzone C, Lucia E, Morabito L, Gigliotti V, Stefano LD, Caruso N, Servillo P, Franzese S, Fimognari F, Bisconte MG, Gentile C, Morabito F. Expert Opin Investig Drugs; 2011 Apr 01; 20(4):465-93. PubMed ID: 21381982 [Abstract] [Full Text] [Related]
15. Epigenetics and cancer treatment. Kristensen LS, Nielsen HM, Hansen LL. Eur J Pharmacol; 2009 Dec 25; 625(1-3):131-42. PubMed ID: 19836388 [Abstract] [Full Text] [Related]
16. Targeting Chromatin Remodeling for Cancer Therapy. Kaur J, Daoud A, Eblen ST. Curr Mol Pharmacol; 2019 Dec 25; 12(3):215-229. PubMed ID: 30767757 [Abstract] [Full Text] [Related]
17. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract. Wang Z, Yue Y, Han P, Sa R, Ren X, Wang J, Bai H, Yu H. Cytotherapy; 2013 Sep 25; 15(9):1164-73. PubMed ID: 23800731 [Abstract] [Full Text] [Related]
18. Small molecule inhibitors of histone acetyltransferases as epigenetic tools and drug candidates. Furdas SD, Kannan S, Sippl W, Jung M. Arch Pharm (Weinheim); 2012 Jan 25; 345(1):7-21. PubMed ID: 22234972 [Abstract] [Full Text] [Related]
19. Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy. Morera L, Lübbert M, Jung M. Clin Epigenetics; 2016 Jan 25; 8():57. PubMed ID: 27222667 [Abstract] [Full Text] [Related]
20. Cancer type-specific epigenetic changes: gastric cancer. Calcagno DQ, de Arruda Cardoso Smith M, Burbano RR. Methods Mol Biol; 2015 Jan 25; 1238():79-101. PubMed ID: 25421656 [Abstract] [Full Text] [Related] Page: [Next] [New Search]